- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,449GBP
- Report
- January 2026
- 240 Pages
Global
From €3204EUR$3,613USD£2,775GBP
€3770EUR$4,250USD£3,264GBP
- Report
- October 2025
- 256 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- February 2026
- 120 Pages
Global
From €5278EUR$5,950USD£4,570GBP
- Report
- January 2026
- 150 Pages
Global
From €5278EUR$5,950USD£4,570GBP
- Report
- October 2025
- 120 Pages
Global
From €5278EUR$5,950USD£4,570GBP
- Report
- July 2025
- 118 Pages
Global
From €5278EUR$5,950USD£4,570GBP
- Report
- February 2026
- 250 Pages
Global
From €3983EUR$4,490USD£3,449GBP
- Report
- February 2026
- 250 Pages
Global
From €3983EUR$4,490USD£3,449GBP
- Report
- August 2025
- 183 Pages
Global
From €3144EUR$3,545USD£2,723GBP
€3494EUR$3,939USD£3,025GBP
- Report
- January 2026
- 181 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 180 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 180 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 181 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 181 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 183 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 180 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 180 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 185 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- January 2026
- 185 Pages
Global
From €3991EUR$4,500USD£3,456GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more